Mr Sotirios Temopoulos had a medical history that included multiple myeloma with a myelomataus lesion in his cervical spine, in which he was prescribed a fentanyl patch and pregabalin for neuropathic pain.
He also lived with a deep vein thrombosis, pulmonary embolism, meningitis, liver steatosis, depression, pre-diabetes, metabolic syndrome, chronic renal impairment, hypercholesteraemia, and had suffered a stroke.
At the time of his death, Mr Temopoulos received a weekly DAA from Quality Pharmacy in a separate DAA to those of his wife, Ekaterini.
In his DAA were:
- metabolic syndrome
- colecalcirerol
- coloxyl with senna
- oxycodone
- escitalopram
- atorvastatin
- pantoprazole
- aspirin
- valaciclovir
- lenalidomide
- oxycodone/naloxone (Targin).
Earlier in July 2020, Mr Temopoulos began taking lenalidomide, a chemotherapy drug, for his multiple myeloma, which was infused at Box Hill Hospital once a month. However, on 20 July, after a fall from his bed, he could not attend due to increasing back and kidney pain which were later diagnosed as lumbar spine fractures and he spent several days in hospital.


Team PSA 2026: Caroline Diamantis FPS, Prof Mark Naunton MPS and Bridget Totterman MPS[/caption]
A/Prof Fei Sim and Prof Mark Naunton[/caption]

Clinical features
Warm compresses are the cornerstone of treatment, helping to soften the lesion, bring pus to the surface and encourage spontaneous drainage. A clean face cloth soaked in warm (not hot) water should be applied to the closed eyelid for 2–5 minutes, twice daily during the active phase. Once the stye begins to drain, any discharge should be gently wiped away using a clean, warm washcloth. After resolution, continuing warm compresses once daily may help prevent recurrence.2 






